Key industry experts predict that the remote patient monitoring market will generate $25.1 billion in revenue by 2030, with a high CAGR of 6.5% between 2023 and 2030. The market for remote patient monitoring had been estimated around $10.8 billion in 2022.
According to an opinion from key industry experts Sports Medicine Market revenue is expected to achieve $10.1 Billion at a high CAGR of 6.5% from 2023 to 2030. In 2022, the Sports Medicine Market was estimated at $6.2 Billion.
According to an opinion from key industry experts Alternative Protein Market revenue is expected to attain $26.2 billion at a high CAGR of 9.0% from 2023 to 2030. In 2022, the Alternative Protein Market was estimated at $14.0 billion.
The medical imaging market is made up of the sales of medical and diagnostic imaging equipment and machines like X-ray, CT, MRI, ultrasound, OCT, and combined imaging systems (including nuclear imaging), software, consumables, and accessories from MedTech suppliers and other medical suppliers to hospitals, clinics, research institutes, and educational institutions for use in different medical fields.
In the flavor and fragrance market, manufacturers produce natural and synthetic ingredients sold for and used for food and beverages, pharmaceuticals and healthcare, cleaning and homecare, fabric care, beauty and…
The global dermal filler market revenue size jumped to US $3,571.6 million from an estimated US $2,157.6 million in 2020 at a growth rate of 65.5%. This is attributed to a strong recovery from the COVID-19 pandemic, and new product launches as well as increased brand investments. Further, the global dermal filler market revenue size is forecasted to reach US $10,309.5 million by 2030 at a CAGR of around 12.5%.
The telemedicine market is expected to grow at a CAGR of 40.4% from 2022 to reach $627.5 billion in 2030. Telemedicine has become one of the fastest growing healthcare technologies owing to its ability to overcome routine health management challenges. Its adoption was majorly accelerated during COVID-19 due to critical chronic disease management, its ability to reduce health management costs, rising mental health concerns, substantial government support from developing and developed nations, and coverage of telemedicine consultations under health insurance.
Cancer immunotherapy market is expected to grow at the CAGR between 9-10% from 2022 to 2030 as this therapy is being rapidly adopted in the cancer treatment space. The major market drivers such as higher efficiency of cancer immunotherapy than traditional cancer treatments, rise in global cancer burden, initiatives by government cancer care funding, and easy reimbursement for cancer immunotherapy increase the overall acceptance of this therapy and boost the growth of the market. Owing to these factors global cancer immunotherapy market is expected to cross the $200 billion market size by 2030.
The natural hemp market has witnessed tremendous development in recent years, attributed to cannabidiol (CBD) products such as CBD oil’s popularity among wellness enthusiasts. The industry expects that CBD oil…
The world has registered more than 85.6 million cases and witnessed deaths adjacent to 1.85 million by the start of 2021. No drug has been proven 100% effective against the virus, although a few drugs, namely, Remdesivir, Hydroxcholroquine, Favipiravir, Cipremi, Azithromycin have been in the limelight. A Vaccine seems to be the permanent cure that will result in the end of the pandemic. Researchers around the globe are working diligently to find a vaccine against SARS-CoV-2, the COVID-19 virus. Many vaccines are under clinical trials and a few have been authorized to the date. This has led to the establishment of an enormous market in the global pharmaceutical industry.
Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.
